Sažetak Cilj: Ispitati razine serumskog kalprotektina u bolesnika oboljelih od SLE-a i
ustanoviti jesu li više u odnosu na zdrave ispitanike, ali i ovise li o samoj aktivnosti bolesti …

Background: Serum calprotectin, also known as MRP8/14 or S100A8/A9, has gained
attention in recent years as a candidate biomarker in inflammatory diseases like SLE. 1 …

Objective The aim of this pilot-study was to examine serum calprotectin levels (sCAL) in
patients with SLE and determine possible association with disease activity and history of …

Several key player factors, such as cytokine and complement, play an important role in the
pathogenesis of systemic lupus erythematosus (SLE). Te purpose of this study was to reveal …

Background: There was limited data concerning predicting ability of calprotectin for disease
activity of rheumatoid arthritis (RA) patients with normal C-reactive protein (CRP) level. This …

Calprotectin (L1) is a granulocyte and monocyte cytosolic protein released during activation
of these cells. The plasma level of L1 has been shown to be a good marker of disease …

Several key player factors, such as cytokine and complement, play an important role in the
pathogenesis of systemic lupus erythematosus (SLE). Te purpose of this study was to reveal …

Aim of the work To measure the levels of serum calprotectin (CLP) in rheumatoid arthritis
(RA) and osteoarthritis (OA) patients and to assess its association with disease activity …

Background: Rheumatoid Arthritis (RA) is the most common type of chronic inflammatory
arthritis with unknown etiology marked by a symmetric, peripheral polyarthritis. Calprotectin …

Background Assessment of disease activity in rheumatoid arthritis (RA) is crucial to optimize
the response to treatment and prevent radiographic progression. DAS28 is the most …